These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32611211)

  • 41. The Consortium for Food Allergy Research (CoFAR): The first generation.
    Sampson HA; Berin MC; Plaut M; Sicherer SH; Jones S; Burks AW; Lindblad R; Leung DYM; Wood RA
    J Allergy Clin Immunol; 2019 Feb; 143(2):486-493. PubMed ID: 30586557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy.
    Pajno GB; Fernandez-Rivas M; Arasi S; Roberts G; Akdis CA; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; Ebisawa M; Eigenmann P; Knol E; Nadeau KC; Poulsen LK; van Ree R; Santos AF; du Toit G; Dhami S; Nurmatov U; Boloh Y; Makela M; O'Mahony L; Papadopoulos N; Sackesen C; Agache I; Angier E; Halken S; Jutel M; Lau S; Pfaar O; Ryan D; Sturm G; Varga EM; van Wijk RG; Sheikh A; Muraro A;
    Allergy; 2018 Apr; 73(4):799-815. PubMed ID: 29205393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.
    Burks AW; Wood RA; Jones SM; Sicherer SH; Fleischer DM; Scurlock AM; Vickery BP; Liu AH; Henning AK; Lindblad R; Dawson P; Plaut M; Sampson HA;
    J Allergy Clin Immunol; 2015 May; 135(5):1240-8.e1-3. PubMed ID: 25656999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Food allergen immunotherapy: Current status and prospects for the future.
    Wood RA
    J Allergy Clin Immunol; 2016 Apr; 137(4):973-982. PubMed ID: 27059725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.
    Dioszeghy V; Mondoulet L; Puteaux E; Dhelft V; Ligouis M; Plaquet C; Dupont C; Benhamou PH
    Cell Mol Immunol; 2017 Sep; 14(9):770-782. PubMed ID: 27063469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous.
    Jones SM; Burks AW; Dupont C
    J Allergy Clin Immunol; 2014 Feb; 133(2):318-23. PubMed ID: 24636471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response.
    Kulis M; Vickery BP; Burks AW
    Immunol Res; 2011 Apr; 49(1-3):216-26. PubMed ID: 21161431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic perspectives in food allergy.
    Marcucci F; Isidori C; Argentiero A; Neglia C; Esposito S
    J Transl Med; 2020 Aug; 18(1):302. PubMed ID: 32758254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment Approaches to Food Allergy.
    Bohle B; Werfel T
    Handb Exp Pharmacol; 2022; 268():173-193. PubMed ID: 34104993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
    Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
    J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal models of allergen-specific immunotherapy in food allergy: Overview and opportunities.
    Larsen JM; Bøgh KL
    Clin Exp Allergy; 2018 Oct; 48(10):1255-1274. PubMed ID: 29920810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.
    Lanser BJ; Leung DYM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):153-161. PubMed ID: 29081025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
    Kim EH; Burks AW
    Allergy; 2020 Jun; 75(6):1337-1346. PubMed ID: 32034781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allergen immunotherapy: FAQs and facts].
    Mortasawi V; Pfützner W
    Hautarzt; 2021 Sep; 72(9):760-769. PubMed ID: 34402919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Future therapies for food allergy.
    McWilliams LM; Mousallem T; Burks AW
    Hum Vaccin Immunother; 2012 Oct; 8(10):1479-84. PubMed ID: 22894951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy for food allergies in children.
    Martinolli F; Carraro S; Berardi M; Ferraro V; Baraldi E; Zanconato S
    Curr Pharm Des; 2014; 20(6):906-23. PubMed ID: 23701567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Food allergy in childhood].
    Beyer K; Niggemann B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jun; 59(6):732-6. PubMed ID: 27207693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment for food allergy: Current status and unmet needs.
    Dantzer JA; Kim EH; Chinthrajah RS; Wood RA
    J Allergy Clin Immunol; 2023 Jan; 151(1):1-14. PubMed ID: 35998790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging Approaches to Food Desensitization in Children.
    Hamad A; Burks WA
    Curr Allergy Asthma Rep; 2017 May; 17(5):32. PubMed ID: 28429307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.